FigureĀ 1.
MRD analysis. Sankey plot of MRD assessment in the BM at baseline and at cycles 4, 7, and 10 (C4-C10) with LEN, VEN, and rituximab in R/R MCL. Numbers at the bottom refer to the number of patients with MRD test available at the different cycles/number of patients on treatment.